# Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block

> **NCT06294665** · PHASE1 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Hip Fractures
- Post Operative Pain

## Interventions

- **DRUG:** Pericapsular Nerve Group (PENG) Block

## Key facts

- **NCT ID:** NCT06294665
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06294665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06294665, "Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06294665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*